Literature DB >> 20676946

Parallel thermal analysis technology using an infrared camera for high-throughput evaluation of active pharmaceutical ingredients: a case study of melting point determination.

Kohsaku Kawakami1.   

Abstract

Various techniques for physical characterization of active pharmaceutical ingredients, including X-ray powder diffraction, birefringence observation, Raman spectroscopy, and high-performance liquid chromatography, can be conducted using 96-well plates. The only exception among the important characterization items is the thermal analysis, which can be a limiting step in many cases, notably when screening the crystal/salt form. In this study, infrared thermal camera technology was applied for thermal characterization of pharmaceutical compounds. The melting temperature of model compounds was determined typically within 5 min, and the obtained melting temperature values agreed well with those from differential scanning calorimetry measurements. Since many compounds can be investigated simultaneously in this infrared technology, it should be promising for high-throughput thermal analysis in the pharmaceutical developmental process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676946      PMCID: PMC2974158          DOI: 10.1208/s12249-010-9498-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

1.  Coherent thermal wave imaging of subsurface chromophores in biological materials.

Authors:  Sergev A Telenko; Gracie Vargas; J Stuart Nelson; Thomas E Milner
Journal:  Phys Med Biol       Date:  2002-02-21       Impact factor: 3.609

2.  Crystallization and transitions of sulfamerazine polymorphs.

Authors:  Geoff G Z Zhang; Chonghui Gu; Mark T Zell; R Todd Burkhardt; Eric J Munson; David J W Grant
Journal:  J Pharm Sci       Date:  2002-04       Impact factor: 3.534

3.  An investigation into the subambient behavior of aqueous mannitol solutions using differential scanning calorimetry, cold stage microscopy, and X-ray diffractometry.

Authors:  Vicky L Kett; Shaun Fitzpatrick; Brett Cooper; Duncan Q M Craig
Journal:  J Pharm Sci       Date:  2003-09       Impact factor: 3.534

4.  Trends in solubility of polymorphs.

Authors:  Madhu Pudipeddi; Abu T M Serajuddin
Journal:  J Pharm Sci       Date:  2005-05       Impact factor: 3.534

5.  Identifying the stable polymorph early in the drug discovery-development process.

Authors:  Jonathan M Miller; Benjamin M Collman; Landon R Greene; David J W Grant; Anthony C Blackburn
Journal:  Pharm Dev Technol       Date:  2005       Impact factor: 3.133

Review 6.  Designing a molecular delivery system within a preclinical timeframe.

Authors:  Jan-Olav Henck; Stephen R Byrn
Journal:  Drug Discov Today       Date:  2007-02-09       Impact factor: 7.851

Review 7.  Current status of amorphous formulation and other special dosage forms as formulations for early clinical phases.

Authors:  Kohsaku Kawakami
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

8.  Ritonavir: an extraordinary example of conformational polymorphism.

Authors:  J Bauer; S Spanton; R Henry; J Quick; W Dziki; W Porter; J Morris
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

9.  Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate.

Authors:  Y Kobayashi; S Ito; S Itai; K Yamamoto
Journal:  Int J Pharm       Date:  2000-01-05       Impact factor: 5.875

10.  Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.

Authors:  Kieran J Crowley; George Zografi
Journal:  J Pharm Sci       Date:  2002-02       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.